Free Trial

Creo Medical Group (LON:CREO) Trading Down 2.9% - Here's Why

Creo Medical Group logo with Medical background
Remove Ads

Creo Medical Group PLC (LON:CREO - Get Free Report) shares were down 2.9% during mid-day trading on Wednesday . The stock traded as low as GBX 12.75 ($0.17) and last traded at GBX 12.75 ($0.17). Approximately 360,594 shares were traded during trading, a decline of 50% from the average daily volume of 715,357 shares. The stock had previously closed at GBX 13.13 ($0.17).

Creo Medical Group Price Performance

The firm has a market capitalization of £52.55 million, a price-to-earnings ratio of -2.06 and a beta of 0.86. The company has a quick ratio of 2.19, a current ratio of 3.24 and a debt-to-equity ratio of 29.96. The stock's 50-day moving average price is GBX 15.85 and its 200 day moving average price is GBX 18.75.

Insiders Place Their Bets

In other Creo Medical Group news, insider Christopher Paul Hancock bought 4,712 shares of the business's stock in a transaction on Monday, January 20th. The stock was bought at an average price of GBX 19 ($0.25) per share, with a total value of £895.28 ($1,158.79). Corporate insiders own 22.43% of the company's stock.

About Creo Medical Group

(Get Free Report)

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. The Company's vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.

See Also

Should You Invest $1,000 in Creo Medical Group Right Now?

Before you consider Creo Medical Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Creo Medical Group wasn't on the list.

While Creo Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

7 Inflation-Proof Stocks to Protect Your Portfolio

7 Inflation-Proof Stocks to Protect Your Portfolio

Inflation is sticking around—is your portfolio ready? In this video, we break down 7 stocks that could help shield your investments from inflation’s impact.

Related Videos

Pelosi Bets Big on AI: Her Top 5 Stock Picks
7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025
3 Stocks Insiders Are Selling, But Analysts Still Love

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads